F-1/A: Meiwu Technology Company Limited Files Amendment No. 2 to Form F-1 for Share Offering

Sentiment:

Prospectus


Meiwu Technology Company Limited has filed an amendment to its Form F-1 registration statement for a proposed offering of 30,000,000 ordinary shares, along with a secondary offering of 30,000,000 shares by a selling shareholder.

Capital raiseThe document details a primary offering of 30,000,000 ordinary shares by the company.It also includes a secondary offering of 30,000,000 ordinary shares by a selling shareholder, Changbin Xia.The company will receive proceeds from the primary offering, but not from the sale of shares by the selling shareholder.
Worse than expectedThe company's revenue decreased significantly due to the suspension of its SMS business.The company's gross profit decreased significantly due to the decrease in revenue.The company's operating expenses decreased, but not enough to offset the decrease in revenue.The company's net loss increased compared to the same period last year.

Summary

  • Meiwu Technology Company Limited, a British Virgin Islands holding company, has filed an amendment to its Form F-1 registration statement.
  • The document outlines a primary offering of 30,000,000 ordinary shares by the company.
  • It also includes a secondary offering of 30,000,000 ordinary shares by a selling shareholder, Changbin Xia, the Chairman of the Company.
  • Mr. Xia purchased his shares at $0.80 per share on October 22, 2024.
  • The primary offering is a best-efforts offering with no minimum purchase requirement.
  • The shares will be offered at a fixed price of $[] per share.
  • The company will receive proceeds from the primary offering, but not from the sale of shares by the selling shareholder.
  • The net proceeds from the primary offering will be used for recruitment, online platform upgrades, distribution network expansion, and marketing activities for a planned functional skincare business.
  • The company's ordinary shares are listed on the Nasdaq Capital Market under the symbol WNW.
  • The last reported sale price of the ordinary shares on Nasdaq was $0.7990 per share on November 14, 2024.
  • The company operates through a VIE structure in China, which involves unique risks to investors.
  • The document also discusses risks related to the VIE structure, PRC regulations, and the Holding Foreign Companies Accountable Act.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are positive aspects such as the expansion into the functional skincare market and the listing on Nasdaq, the significant risks associated with the VIE structure, PRC regulations, and the company's financial performance create a negative sentiment.

Positives

  • The company is expanding into the functional skincare market, which could provide new revenue streams.
  • The company has a listing on the Nasdaq Capital Market, providing access to U.S. investors.
  • The company has a detailed plan for the use of proceeds from the primary offering.

Negatives

  • The company operates through a VIE structure, which carries significant regulatory and operational risks.
  • The company is subject to the Holding Foreign Companies Accountable Act, which could lead to delisting.
  • The company is subject to the risks of uncertainty about any future actions of the PRC government.
  • The company has a limited operating history and will face intense competition in the beauty industry.
  • The company relies on third-party manufacturers for its products and formulas.

Risks

  • The VIE structure may not be effective in providing control over the VIE.
  • The Chinese government may intervene or influence the company's operations.
  • The company may be subject to severe penalties or be forced to relinquish its interests in those operations if the VIE structure is deemed non-compliant.
  • The company's ordinary shares may decline in value or become worthless if the company is unable to assert contractual control over the assets of its PRC subsidiaries or the VIE.
  • The company is subject to certain legal and operational risks associated with being based in China.
  • The company's ordinary shares may be delisted if the PCAOB is unable to inspect the company's auditor.
  • The company is subject to the risks of an economic recession, credit and capital markets volatility and economic and financial crisis as a result of the COVID-19 virus pandemic.
  • The company may not be able to successfully implement its growth strategy.
  • The company depends on third parties to supply its food products; any adverse changes in such supply or the costs of products may adversely affect its operations.
  • The company may be subject to infringement claims of intellectual property rights or other rights of third parties, which may be expensive to defend and may disrupt its business and operations.

Future Outlook

The company plans to use the net proceeds from the primary offering for the recruitment of talented personnel in sales and technical departments for its planned functional skincare business; for the operation of and the upgrade of its online platform to add a new functional skincare segment; for establishing and expanding its distribution network for the planned functional skincare business; and for marketing and promotional activities to enhance market share and drive sales of its business.

Management Comments

  • Our management team will have broad discretion over the use of the net proceeds from this offering, if any, and you may not agree with how we use the proceeds and the proceeds may not be invested successfully.
  • Our management is directly supervising cash management.

Industry Context

The document highlights the competitive nature of the beauty industry and the need for the company to adapt to changing consumer preferences and industry trends. It also discusses the regulatory environment in China and the potential impact on the company's operations.

Comparison to Industry Standards

  • The document does not provide specific comparisons to industry standards or competitors.
  • However, it mentions that the company will face competition from both domestic and international players in China in the beauty industry, including large multinational consumer products companies that own or operate multiple beauty brands.
  • It also notes that many domestic and multinational consumer goods companies have greater financial, technical or marketing resources, longer operating histories, greater brand recognition or larger customer bases than the company.

Related Party Transactions

  • The document discloses amounts due to Eternal Horizon International Company Limited and Changbin Xia.
  • It also mentions purchases from and sales to related parties.

Stakeholder Impact

  • Shareholders face risks related to the VIE structure, PRC regulations, and potential delisting.
  • Employees may benefit from the company's expansion and hiring plans.
  • Customers may benefit from the company's new functional skincare products.
  • Suppliers may benefit from the company's expansion and increased demand for products.

Next Steps

  • The company plans to use the net proceeds from the primary offering for the recruitment of talented personnel in sales and technical departments for its planned functional skincare business; for the operation of and the upgrade of its online platform to add a new functional skincare segment; for establishing and expanding its distribution network for the planned functional skincare business; and for marketing and promotional activities to enhance market share and drive sales of its business.

Key Dates

DateDescription
2015-06-16Meiwu Shenzhen was incorporated.
2018-12-04Meiwu Technology Company Limited was incorporated.
2019-03-02VIE Agreements were entered into.
2020-10-20Meiwu Shenzhen entered into an Equity Transfer Agreement to acquire 51% equity interests in Baode.
2020-12-10Meiwu Shenzhen incorporated Wunong Technology (Shaanxi) Co., Ltd.
2020-12-15Meiwu Shenzhen transferred the 51% ownership interest in Baode to Yafang Liu.
2020-12-17Meiwu Technology Company Limited initial public offering closed.
2021-01-28Meiwu Shenzhen repurchased the 51% ownership interest in Baode.
2021-04-29Baodes registered capital was increased to RMB 30 million.
2021-09-16Meiwu Shenzhen entered into a loan agreement with Shenzhen Qianhai Weizhong Bank.
2021-11-23Meiwu entered into a Share Purchase Agreement with Boxinrui International Holdings Limited.
2021-12-28Meiwu Shenzhen sold the 51% equity interests of Baode Supply Chain (Shenzhen) Co., Ltd.
2022-01-06Meiwu Shenzhen entered into a loan agreement with China Construction Bank.
2022-02-23Shenzhen BaoAn Industrial Investment Group Co Ltd entered into a lease with Meiwu Shenzhen.
2022-03-31Meiwu entered into a Share Purchase Agreement with Magnum International Holdings Limited.
2022-04-19The closing of the Yundian SPA occurred.
2022-05-12Meiwu Shenzhen established Heme Brand Chain Management (Shenzhen) Co., Ltd.
2022-06-23Meiwu entered into a Share Purchase Agreement with Mahaotiaodong Information Technology Company Limited and the closing of the Mahao SPA occurred.
2022-07-22Heme Shenzhen established Heme Catering Management (Shenzhen) Co., Ltd.
2022-10-14Meiwu Shenzhen entered into a loan agreement with China Construction Bank.
2022-12-12Meiwu entered into a Share Purchase Agreement with Xinfuxin International Holdings Limited.
2022-12-15The PCAOB issued a HFCA Act determination report that vacated its December 16, 2021 determinations.
2022-12-23The closing of the Yuanxing SPA occurred.
2023-01-01Wunong Net Technology Company Limited changed its name to Meiwu Technology Company Limited.
2023-03-24The company suspended the business of Wunong Shaanxi.
2023-05-04Meiwu Shenzhen established Shenzhen Jiayuan Liquor Sales Co., Ltd.
2023-10-31Meiwu Shenzhen entered into a loan agreement with China Construction Bank.
2024-02-21The Company adopted a share incentive plan, which is referred to as the 2024 Equity Incentive Plan.
2024-03-16Meiwu Shenzhen entered into a loan agreement with Shenzhen Qianhai Weizhong Bank.
2024-05-17The Company entered into a securities purchase agreement with three unaffiliated investors.
2024-10-22Mr. Xia purchased 30,000,000 Ordinary Shares at a per share price of $0.80.
2024-11-14The last reported sale price of the ordinary shares on Nasdaq was $0.7990 per share.
2024-11-18The date of this prospectus.

Keywords

Meiwu Technology, Ordinary Shares, Initial Public Offering, VIE Structure, China, Functional Skincare, Nasdaq, Holding Foreign Companies Accountable Act, Securities Purchase Agreement, Best Efforts Offering

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.